Suicide Squad topped foreign box office charts for a second consecutive week.

The supervillain adventure picked up $58.7 million from 15,600 screens across 62 territories, pushing its global gross to $465.4 million. That’s a big haul, but Warner Bros spent lavishly on the film, shelling out $175 million to produce the film and north of $100 million to market it. It needs to be one of the year’s biggest hits for the studio to turn a profit. To that end, the film is fighting bad reviews and poor word-of-mouth as it tries to keep bringing in crowds.

It also has been denied an entry into China, depriving it of as much as $100 million in revenue from the world’s second biggest market for film.

Suicide Squad opened in Argentina and Italy over the weekend, picking up $2.5 million and $2.2 million, respectively.

The film is fighting bad reviews and poor word-of-mouth as it tries to keep bringing in crowds

Among holdover territories, the film nabbed $6.7 million in Brazil, $5.5 million in the UK, $4.4 million in Australia, $4.3 million in Mexico, and $4.3 million in Russia. Domestically, the film slid a painful 67 per cent in its second weekend, earning $43.8 million.

In second place, Illumination Entertainment and Universal’s The Secret Life of Pets racked up $40 million from 48 territories. The animated hit centres on what animals do while their masters are at work, and has made $592.6 million globally on a $75 million budget. It opened in first place in Japan this weekend with $10 million.

After its second week of release in China, The Secret Life of Pets has generated $49.1 million.

Line Walker, a Hong Kong-Chinese crime film, took third place, earning $26 million. Universal’s Jason Bourne picked up $18.6 million from 60 foreign territories, bringing its global gross to $246.2 million. Love 020, another Chinese release, rounded out the top five, earning $17.5 million.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.